Immunethep receives grant to advance antibody product development for bacterial infections

October 23, 2017
IMMUNETHEP, SA

Immunethep, a biotech company based in Portugal that is developing antibacterial immunotherapies, has received a grant from the Bill & Melinda Gates Foundation to test an antibody product.

 

Full Press Release available: